Anavex Life Sciences
AVXL
£6.72
Share price
-2.74%
Change (1 day)
106.93%
Change (1 year)
Categories
Anavex Life Sciences (AVXL) - Total debt
Total debt on the balance sheet as of June 2016 : £0.06 Million
According to Anavex Life Sciences 's latest financial reports the company's total debt is £0.06 Million. A company’s total debt is the sum of all current and non-current debts.
Anavex Life Sciences - Total debt on balance sheet (from 2006 to 2016)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2015-09-30 | £0.05 M | -98.45% |
| 2014-09-30 | £3.64 M | 429.4% |
| 2013-09-30 | £0.68 M | 271.43% |
| 2012-09-30 | £0.18 M | -66.63% |
| 2011-09-30 | £0.55 M | -64.96% |
| 2010-09-30 | £1.58 M | -5.71% |
| 2009-09-30 | £1.68 M | 92.05% |
| 2008-09-30 | £0.87 M | |
| 2006-09-30 | £0.01 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | £3.24 M | 4,941.25% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | £0.57 B | 900,916.64% | 🇺🇸 USA |
 Corcept Therapeutics
CORT | £4.98 M | 7,646.62% | 🇺🇸 USA |
 Palatin Technologies PTN | £0.19 M | 197.19% | 🇺🇸 USA |